Mayo分诊算法在晚期上皮性卵巢癌个体化手术管理中的外部验证
本研究外部验证Mayo分诊算法在晚期上皮性卵巢癌(AEOC)治疗策略管理中的性能,纳入179例接受初次减瘤术(PDS)的患者,分为高风险组(32例)和分诊适当组(147例)。结果显示高风险组手术复杂度和最佳减瘤比例更低,30天并发症发生率和无法接受辅助化疗的比例更高。结论认为该算法可用于高风险AEOC患者的个体化初始管理,但长期管理可行性需进一步探索。
要点
- 高风险组30天并发症发生率28%,显著高于分诊适当组的5%(P<0.01)。
- 高风险组最佳减瘤比例50%,低于分诊适当组的71%(P<0.05)。
- 高风险组无法接受PDS后辅助化疗的比例22%,高于分诊适当组的2%(P<0.01)。
核心结论
- Mayo分诊算法用于AEOC治疗决策的有效性在本研究中获得外部确认。
- 该短期并发症评估工具可有效用于高风险AEOC患者的个体化初始管理。
- 该算法用于长期管理的可行性有待进一步探索。
研究设计与样本
- 外部验证研究,纳入179例接受初次减瘤手术(PDS)的晚期上皮性卵巢癌(AEOC)患者。
- 按Mayo分诊算法分为高风险组(32例)和分诊适当组(147例),比较两组手术结局和并发症。
主要发现
- 高风险组患者年龄更大、体能状态更差、术前血清白蛋白更低(P<0.01)。
- 高风险组接受中/高复杂度手术的比例为38%,低于分诊适当组的72%(P<0.01)。
- 高风险组最佳减瘤比例为50%,低于分诊适当组的71%(P<0.05)。
- 高风险组30天并发症发生率为28%,高于分诊适当组的5%(P<0.01)。
- 高风险组PDS后无法接受辅助化疗的比例为22%,高于分诊适当组的2%(P<0.01)。
临床怎么用
- 可将Mayo分诊算法用于AEOC患者初次手术前的风险评估和个体化治疗决策。
- 对高风险AEOC患者应关注术后30天并发症及辅助化疗可行性。
局限性
- 样本量有限,高风险组仅32例。
- 90天死亡率差异未达统计学意义,长期管理可行性需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To externally validate the performance of the Mayo triage algorithm applied to treatment strategy management in advanced epithelial ovarian cancer (AEOC) patients. METHODS: AEOC patients who underwent primary debulking surgery (PDS) were included and were divided into two groups based on the Mayo triage algorithm: "high risk" and "triage appropriate". The surgery outcomes and complications of the patients were compared between the two groups. RESULTS: 179 consecutive AEOC patients were enrolled for analysis, including 32 patients in the high-risk group and 147 patients in the triage-appropriate group. The results showed that patients in the high-risk group were older, had worse physical status and had lower preoperative serum albumin than those in the triage-appropriate group (P<0.01). The high-risk group had a lower proportion of women who underwent intermediate/high complexity surgery (38% vs. 72%, P<0.01) as well as a lower proportion of women who underwent optimal resection (50% vs. 71%, P<0.05). Furthermore, the incidence of 30-day complications (28% vs. 5%, P<0.01) and the proportion of patients who were unable to undergo adjuvant chemotherapy after PDS (22% vs. 2%, P<0.01) were both significantly higher in the high-risk group than in the triage-appropriate group. In addition, compared to the triage-appropriate group, the 90-day mortality rate in the high-risk group was also notably higher, but the difference was not statistically significant (6% vs. 1%, P=0.15). CONCLUSION: The validity of the Mayo triage algorithm for treatment decision-making in AEOC was externally confirmed in this study. This short-term complication assessment tool could be effectively used for the individualized primary management of high-risk AEOC patients. The feasibility of the Mayo triage algorithm for use in long-term management should be further explored.
引用
- Jiang C, Li Z. Performance validation of the Mayo triage algorithm applied to individualize surgical management of advanced epithelial ovarian cancer. Gynecol Oncol. 2021. PMID: 34147283. doi:10.1016/j.ygyno.2021.06.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。